Question 1

Does Boston Trust Walden own HALO stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Boston Trust Walden holds 1,083,062 shares of HALO (Halozyme Therapeutics), worth $84.8M.

Question 2

How many shares of HALO does Boston Trust Walden own?

Accepted Answer

As of its Q2 2026 13F, Boston Trust Walden holds 1,083,062 shares of HALO (Halozyme Therapeutics).

Question 3

What is Boston Trust Walden's HALO position worth?

Accepted Answer

As of its Q2 2026 13F, Boston Trust Walden's HALO position is worth $84.8M.

Question 4

Is Boston Trust Walden buying or selling HALO?

Accepted Answer

In Q2 2026, Boston Trust Walden increased its HALO position by 403,499 shares (+59.4%).

Question 5

When did Boston Trust Walden first buy HALO?

Accepted Answer

Boston Trust Walden first reported HALO in its Q2 2024 13F and has listed it in 9 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.1M	+59.4%	$84.8M	0.6%	$78.27	60
2026-Q1	Decreased	679,563	-13.1%	$43.9M	0.4%	$64.63	0
2025-Q4	Decreased	781,835	-6.2%	$52.6M	0.4%	$67.30	0
2025-Q3	Decreased	833,893	-1.3%	$61.2M	0.4%	$73.34	0
2025-Q2	Decreased	845,246	-2.5%	$44M	0.3%	$52.02	0
2025-Q1	Decreased	866,872	-0.8%	$55.3M	0.4%	$63.81	0
2024-Q4	Increased	874,081	+28.1%	$41.8M	0.3%	$47.81	43
2024-Q3	Increased	682,616	+54.0%	$39.1M	0.3%	$57.24	49
2024-Q2	New	443,295	-	$23.2M	0.2%	$52.36	47

HALO9 quarters

HALO
9 quarters